LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

Kodu・Aktsiate loetelu・Abbott Laboratories

Abbott Laboratories

Suletud

Sektor Tervishoid

116.97 -1.98

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

116.63

Max

118.62

Põhinäitajad
By Trading Economics
Sissetulek	77M 1.3B
Müük	220M 11B
P/E Sektori keskmine	32.37 112.16
Aktsiakasum	1.21
Kasumimarginaal	12.543
Töötajad	114,000
EBITDA	170M 2.6B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+10.8 upside

Dividendid
By Dow Jones
Järgmine dividendimakse kuupäev	15. nov 2024
Järgmine aktsia dividendi kuupäev (ex-date)	9. jaan 2025

Turustatistika
By TradingEconomics
Turukapital	7.2B 204B
Eelmine avamishind	118.95
Eelmine sulgemishind	116.97

Uudiste sentiment

By Acuity

39%

61%

117 / 366 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

115.95 / 119.52 Toetus ja vastupanu

Abbott Laboratories Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. okt 2024, 12:03 UTC

Tulu

Abbott Laboratories 3Q Sales Top Expectations

29. juuli 2024, 10:30 UTC

Suurimad hinnamuutused turgudel

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29. juuli 2024, 09:27 UTC

Suurimad hinnamuutused turgudel

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18. juuli 2024, 12:21 UTC

Tulu

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

16. okt 2024, 14:21 UTC

Peamised uudised

Tulu

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16. okt 2024, 12:25 UTC

Tulu

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16. okt 2024, 12:02 UTC

Peamised uudised

Tulu

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16. okt 2024, 11:59 UTC

Tulu

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16. okt 2024, 11:37 UTC

Tulu

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

16. okt 2024, 11:36 UTC

Tulu

Abbott Labs Sees 4Q EPS 96c-EPS $1.02 >ABT

16. okt 2024, 11:35 UTC

Tulu

Abbott Labs: Well-positioned to Achieve Upper End of Our Initial Guidance Ranges for Yr and Have Great Momentum Heading Into Next Yr >ABT

16. okt 2024, 11:35 UTC

Tulu

Abbott Labs Maintains Full-Yr 2024 Organic Sales Growth Guidance Range of 9.5% to 10.0%, Excluding COVID-19 Testing-Related Sales >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs 3Q Organic Sales Growth Up 7.6% >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs 3Q Sales $10.64B >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs 3Q Net $1.65B >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs 3Q Adj EPS $1.21 >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY Adj EPS $4.64-Adj EPS $4.70 >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY EPS $3.34-EPS $3.40 >ABT

16. okt 2024, 11:30 UTC

Tulu

Abbott Labs 3Q EPS 94c >ABT

29. juuli 2024, 10:15 UTC

Suurimad hinnamuutused turgudel

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29. juuli 2024, 08:50 UTC

Kuumad aktsiad

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18. juuli 2024, 19:04 UTC

Market Talk

Tulu

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18. juuli 2024, 11:43 UTC

Tulu

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18. juuli 2024, 11:34 UTC

Tulu

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18. juuli 2024, 11:34 UTC

Tulu

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18. juuli 2024, 11:31 UTC

Tulu

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18. juuli 2024, 11:30 UTC

Tulu

Abbott Labs 2Q Sales $10.38B >ABT

Võrdlus sarnastega

Hinnamuutus

Abbott Laboratories Prognoos

Hinnasiht

By TipRanks

10.8% tõus

12 kuu keskmine prognoos

Keskmine 132.29 USD 10.8%

Kõrge 146 USD

Madal 117 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Abbott Laboratories 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

Osta

Hoia

Müü

Põhineb 20 analüütiku instrumendi Abbott Laboratories aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

115.95 / 119.52Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bullish events outweigh bearish events.

Sentiment

By Acuity

117 / 366 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.